期刊文献+

广州地区宫颈癌组织标本中HPV感染情况的初步分析 被引量:14

暂未订购
导出
摘要 目的探讨广州地区宫颈癌患者人乳头瘤病毒(HPV)感染及其型别分布。方法采用HPV通用引物对宫颈癌组织标本中的HPVL1区基因序列进行PCR扩增,根据PCR产物测序所得序列分析对HPV分型。结果130例宫颈癌组织HPVDNA检出率为82.3%,广州宫颈癌患者存在HPV16、33、18、52、11、31、58、68、53和59十种型别。结论证实了生殖道高危型HPV感染是妇女宫颈癌发病的重要因素。
出处 《南方医科大学学报》 CAS CSCD 北大核心 2007年第3期399-400,共2页 Journal of Southern Medical University
  • 相关文献

参考文献11

  • 1Bosh FX,Rohan T,Schnieder A,et al.Papillomavirus research update:highlights of the Barcelona HPV 2000 international papillomavirus conference[J].J Clin Pathol,2001,54(3):163-75.
  • 2IARC working group on the evaluation of carcinogenic risks to humans.IARC monographs on the evaluation of carcinogenic risks to humans.Human papillomavirus[M].Lyon:WHO,1995.64.
  • 3Bosch FX,Lorincz A,Munoz N,et al.The causal relation between human papillomavirus and cervical canter[J].J Clin Pathol,2002,55(4):244-65.
  • 4Sehiffman MH.Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia[J].Natl Cancer Ins,1992,84:394-8.
  • 5Walboomers JM,Jaclbs MV,Manos MM,et al.Human papillomavirus is a necessary cause of invasive cervical cancer worldwide[J].J Pathol,1999,189(1):12-9.
  • 6Prado JC,Calleja-Macias IE,Bernard HU,et al.Worldwide genomic diversity of the human papillomaviruses-53,56 and 66,a group of high-risk HPVs unrelated to HPV-16 and HPV-18[J].Virology,2005,340(1):95-104.
  • 7Bosch FX,Manos MM,Munoz N,et al.Prevalence of human papillomavirus in cervical cancer:a worldwide perspective[J].J Natl Cancer Ins,1995,87(11):796-802.
  • 8吴玉萍,陈裕隆,李隆玉,梁增文,张雁玲.宫颈癌患者人乳头瘤病毒(HPV)主要型别及其感染研究[J].病毒学报,2005,21(4):269-273. 被引量:56
  • 9Wang Z,Konya J,Avail LE,et al.Human papillomavirus antibody response among patients with incident cervical carcinoma[J].J Med Virol,1997,52(4):436-40.
  • 10Varsani A,van der Walt E,Health L,et al.Evidence of ancient papillomavirus recombination[J].J Gen Viorl,2006,87(pt9):2527-31.

二级参考文献15

  • 1Peter J F, Adriaan J C, Chris J L, et al. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity[J]. J Pathol, 2003,201:1 - 6.
  • 2Yamazaki H, Sasagawa T, Basha W, et al. Hybrid capture- Ⅱ and LCR-E7 PCR assays for HPV typing in cervical cytologic sample[J]. Int J Cancer, 2001,94:222 - 227.
  • 3Poljak M, Marin I J, Seme K, et al. Hybrid capture- Ⅱ HPV test detects at least 15 human papillomavirus genetypes not included in its current high risk probe cocktail[J]. J Clin Virol, 2002,25:89 -97.
  • 4Matsukura T, Sugase M. Relations between 80 human papillomavirus genotypes and different grades of cervical intraepithelial neoplasia: association and causality [J]. Virol, 2001,283: 139 -147.
  • 5Lee S A, Kang D, Seo S S, et al. Multiple HPV infection in cervical cancer screened by HPV DNA Chip [J]. Cancer Letters,2003, 198: 187-192.
  • 6Wang Z, Konya J, Avall L E, et al. Human papillomavirus antibody response among patients with incident cervical carcinoma[J].J Med Virol, 1997, 52(4): 436 -440.
  • 7Margaret E C. The role of human papillomavirus in risk management[J]. Gynecol Prac, 2003, 3: 229- 233.
  • 8IARC working group on the evaluation of carcinogenic risks to humans. IARC monographs on the evaluation of carcinogenic risks to humans. Human papillomavirus [M]. Lyon, France: WHO,1995.64.
  • 9Walboomers J M, Jacobs M V, Manos M M, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide[J]. J Pathol, 1999, 198:12- 19.
  • 10Bosch F X, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer[J]. J Clin Pathol,2002, 55:244 - 265.

共引文献55

同被引文献170

引证文献14

二级引证文献295

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部